Search research articles
Contact Us
Filters
Showing results (301-310 of 335) with videos related to
Page
of 34
Sort By:
Antimicrobial Agents and Chemotherapy
|
August 5, 2015
Evaluation of Gallium Citrate Formulations against a Multidrug-Resistant Strain of Klebsiella pneumoniae in a Murine Wound Model of Infection
Mitchell G Thompson, Vu Truong-Le, Yonas A Alamneh, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 12, 2022
Discovery of vimseltinib (DCC-3014), a highly selective CSF1R switch-control kinase inhibitor, in clinical development for the treatment of Tenosynovial Giant Cell Tumor (TGCT)
Timothy M Caldwell, Yu Mi Ahn, Stacie L Bulfer, et al.
Journal of Virology
|
June 19, 2015
An Enhanced Synthetic Multiclade DNA Prime Induces Improved Cross-Clade-Reactive Functional Antibodies when Combined with an Adjuvanted Protein Boost in Nonhuman Primates
Megan C Wise, Natalie A Hutnick, Justin Pollara, et al.
American Journal of Human Genetics
|
November 13, 2001
Origins and divergence of the Roma (gypsies)
D Gresham, B Morar, P A Underhill, et al.
Molecular Cancer Therapeutics
|
August 26, 2021
Vimseltinib: A Precision CSF1R Therapy for Tenosynovial Giant Cell Tumors and Diseases Promoted by Macrophages
Bryan D Smith, Michael D Kaufman, Scott C Wise, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 12, 2022
Discovery of acyl ureas as highly selective small molecule CSF1R kinase inhibitors
Timothy M Caldwell, Michael D Kaufman, Scott C Wise, et al.
Haematologica
|
December 9, 2016
Phase 1 dose-finding study of rebastinib (DCC-2036) in patients with relapsed chronic myeloid leukemia and acute myeloid leukemia
Jorge Cortes, Moshe Talpaz, Hedy P Smith, et al.
Frontiers in Immunology
|
March 13, 2023
Engineered antibody cytokine chimera synergizes with DNA-launched nanoparticle vaccines to potentiate melanoma suppression <i>in vivo</i>
Nicholas J Tursi, Ziyang Xu, Michaela Helble, et al.
Annals of Internal Medicine
|
February 1, 1994
Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study
F M Wigley, R A Wise, J R Seibold, et al.
Antimicrobial Agents and Chemotherapy
|
December 18, 2013
Validation of a novel murine wound model of Acinetobacter baumannii infection
Mitchell G Thompson, Chad C Black, Rebecca L Pavlicek, et al.
Page
of 34
Search research articles
Search
Showing results (301-310 of 335) with videos related to
Sort By:
Page
of 34
Antimicrobial Agents and Chemotherapy
|
August 5, 2015
Evaluation of Gallium Citrate Formulations against a Multidrug-Resistant Strain of Klebsiella pneumoniae in a Murine Wound Model of Infection
Mitchell G Thompson, Vu Truong-Le, Yonas A Alamneh, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 12, 2022
Discovery of vimseltinib (DCC-3014), a highly selective CSF1R switch-control kinase inhibitor, in clinical development for the treatment of Tenosynovial Giant Cell Tumor (TGCT)
Timothy M Caldwell, Yu Mi Ahn, Stacie L Bulfer, et al.
Journal of Virology
|
June 19, 2015
An Enhanced Synthetic Multiclade DNA Prime Induces Improved Cross-Clade-Reactive Functional Antibodies when Combined with an Adjuvanted Protein Boost in Nonhuman Primates
Megan C Wise, Natalie A Hutnick, Justin Pollara, et al.
American Journal of Human Genetics
|
November 13, 2001
Origins and divergence of the Roma (gypsies)
D Gresham, B Morar, P A Underhill, et al.
Molecular Cancer Therapeutics
|
August 26, 2021
Vimseltinib: A Precision CSF1R Therapy for Tenosynovial Giant Cell Tumors and Diseases Promoted by Macrophages
Bryan D Smith, Michael D Kaufman, Scott C Wise, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 12, 2022
Discovery of acyl ureas as highly selective small molecule CSF1R kinase inhibitors
Timothy M Caldwell, Michael D Kaufman, Scott C Wise, et al.
Haematologica
|
December 9, 2016
Phase 1 dose-finding study of rebastinib (DCC-2036) in patients with relapsed chronic myeloid leukemia and acute myeloid leukemia
Jorge Cortes, Moshe Talpaz, Hedy P Smith, et al.
Frontiers in Immunology
|
March 13, 2023
Engineered antibody cytokine chimera synergizes with DNA-launched nanoparticle vaccines to potentiate melanoma suppression <i>in vivo</i>
Nicholas J Tursi, Ziyang Xu, Michaela Helble, et al.
Annals of Internal Medicine
|
February 1, 1994
Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study
F M Wigley, R A Wise, J R Seibold, et al.
Antimicrobial Agents and Chemotherapy
|
December 18, 2013
Validation of a novel murine wound model of Acinetobacter baumannii infection
Mitchell G Thompson, Chad C Black, Rebecca L Pavlicek, et al.
Page
of 34